These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15126376)

  • 1. A novel synthetic inhibitor of CDC25 phosphatases: BN82002.
    Brezak MC; Quaranta M; Mondésert O; Galcera MO; Lavergne O; Alby F; Cazales M; Baldin V; Thurieau C; Harnett J; Lanco C; Kasprzyk PG; Prevost GP; Ducommun B
    Cancer Res; 2004 May; 64(9):3320-5. PubMed ID: 15126376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases.
    Brezak MC; Quaranta M; Contour-Galcera MO; Lavergne O; Mondesert O; Auvray P; Kasprzyk PG; Prevost GP; Ducommun B
    Mol Cancer Ther; 2005 Sep; 4(9):1378-87. PubMed ID: 16170030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
    Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
    Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
    Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC25 Inhibition in Acute Myeloid Leukemia-A Study of Patient Heterogeneity and the Effects of Different Inhibitors.
    Brenner AK; Reikvam H; Rye KP; Hagen KM; Lavecchia A; Bruserud Ø
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells.
    Brezak MC; Valette A; Quaranta M; Contour-Galcera MO; Jullien D; Lavergne O; Frongia C; Bigg D; Kasprzyk PG; Prevost GP; Ducommun B
    Int J Cancer; 2009 Mar; 124(6):1449-56. PubMed ID: 19065668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity.
    Aoyagi Y; Masuko N; Ohkubo S; Kitade M; Nagai K; Okazaki S; Wierzba K; Terada T; Sugimoto Y; Yamada Y
    Cancer Sci; 2005 Sep; 96(9):614-9. PubMed ID: 16128747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual G1 and G2/M phase inhibition by SC-alpha alpha delta 9, a combinatorially derived Cdc25 phosphatase inhibitor.
    Tamura K; Rice RL; Wipf P; Lazo JS
    Oncogene; 1999 Nov; 18(50):6989-96. PubMed ID: 10597298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression.
    Kabakci Z; Käppeli S; Cantù C; Jensen LD; König C; Toggweiler J; Gentili C; Ribaudo G; Zagotto G; Basler K; Pinna LA; Cozza G; Ferrari S
    Sci Rep; 2019 Feb; 9(1):1335. PubMed ID: 30718768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.
    Lavecchia A; Di Giovanni C; Novellino E
    Expert Opin Ther Pat; 2010 Mar; 20(3):405-25. PubMed ID: 20166845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.
    Kiyokawa H; Ray D
    Anticancer Agents Med Chem; 2008 Dec; 8(8):832-6. PubMed ID: 19075565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory functions of the CDC25 phosphatase inhibitor BN82002 via targeting AKT2.
    Kim HG; Yang WS; Hong YH; Kweon DH; Lee J; Kim S; Cho JY
    Biochem Pharmacol; 2019 Jun; 164():216-227. PubMed ID: 30980807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin-4-ylethylamino)-quinoline-5,8-dione.
    Pu L; Amoscato AA; Bier ME; Lazo JS
    J Biol Chem; 2002 Dec; 277(49):46877-85. PubMed ID: 12356752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases.
    Viry E; Anwar A; Kirsch G; Jacob C; Diederich M; Bagrel D
    Int J Oncol; 2011 Apr; 38(4):1103-11. PubMed ID: 21253673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate.
    Song Y; Lin X; Kang D; Li X; Zhan P; Liu X; Zhang Q
    Eur J Med Chem; 2014 Jul; 82():293-307. PubMed ID: 24922544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
    Lazo JS; Nemoto K; Pestell KE; Cooley K; Southwick EC; Mitchell DA; Furey W; Gussio R; Zaharevitz DW; Joo B; Wipf P
    Mol Pharmacol; 2002 Apr; 61(4):720-8. PubMed ID: 11901209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.
    Capasso A; Cerchia C; Di Giovanni C; Granato G; Albano F; Romano S; De Vendittis E; Ruocco MR; Lavecchia A
    Oncotarget; 2015 Nov; 6(37):40202-22. PubMed ID: 26474275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.
    Lavecchia A; Di Giovanni C; Novellino E
    Curr Med Chem; 2009; 16(15):1831-49. PubMed ID: 19442149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies.
    Sur S; Agrawal DK
    Mol Cell Biochem; 2016 May; 416(1-2):33-46. PubMed ID: 27038604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.
    Jing L; Wu G; Hao X; Olotu FA; Kang D; Chen CH; Lee KH; Soliman MES; Liu X; Song Y; Zhan P
    Eur J Med Chem; 2019 Dec; 183():111696. PubMed ID: 31541869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.